Chemoinformaics analysis of 8-Tetrahydroxy-2-methylanthracene-9
Molecular Weight | 286.239 | nRot | 0 |
Heavy Atom Molecular Weight | 276.159 | nRig | 18 |
Exact Molecular Weight | 286.048 | nRing | 3 |
Solubility: LogS | -3.784 | nHRing | 0 |
Solubility: LogP | 3.192 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
nHA | 6 | APOL | 36.5299 |
nHD | 4 | BPOL | 11.7681 |
QED | 0.55 |
Synth | 2.919 |
Natural Product Likeliness | 1.632 |
NR-PPAR-gamma | 0.844 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0.001 |
HIA | 0.244 |
CACO-2 | -5.203 |
MDCK | 0.00000669 |
BBB | 0.004 |
PPB | 0.985 |
VDSS | 0.334 |
FU | 0.0349 |
CYP1A2-inh | 0.92 |
CYP1A2-sub | 0.172 |
CYP2c19-inh | 0.038 |
CYP2c19-sub | 0.059 |
CYP2c9-inh | 0.574 |
CYP2c9-sub | 0.342 |
CYP2d6-inh | 0.219 |
CYP2d6-sub | 0.175 |
CYP3a4-inh | 0.208 |
CYP3a4-sub | 0.088 |
CL | 7.076 |
T12 | 0.743 |
hERG | 0.024 |
Ames | 0.813 |
ROA | 0.08 |
SkinSen | 0.944 |
Carcinogencity | 0.713 |
EI | 0.927 |
Respiratory | 0.247 |
NR-Aromatase | 0.817 |
Antiviral | Yes |
Prediction | 0.760076 |